350
Participants
Start Date
August 19, 2024
Primary Completion Date
September 19, 2024
Study Completion Date
October 19, 2024
Surgery
patients underwent complete excision of the inflammatory breast tissue and some surrounding normal tissue under combined intravenous with inhalation anesthesia. Damaged skin was also removed.
triple anti-tuberculosis drug
Patients took oral rifampin (450 mg/day), isoniazid (300 mg/day), and ethambutol (15 mg/kg/day).
RECRUITING
First affiliated hospital of Harbin medical university, Harbin
First Affiliated Hospital of Harbin Medical University
OTHER